Consensus core clinical data elements for meningiomas (v2021.1).


Journal

Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420

Informations de publication

Date de publication:
04 05 2022
Historique:
pubmed: 19 11 2021
medline: 10 5 2022
entrez: 18 11 2021
Statut: ppublish

Résumé

With increasing molecular analyses of meningiomas, there is a need to harmonize language used to capture clinical data across centers to ensure that molecular alterations are appropriately linked to clinical variables of interest. Here the International Consortium on Meningiomas presents a set of core and supplemental meningioma-specific common data elements (CDEs) to facilitate comparative and pooled analyses. The generation of CDEs followed the 4-phase process similar to other National Institute of Neurological Disorders and Stroke (NINDS) CDE projects: discovery, internal validation, external validation, and distribution. The CDEs were organized into patient- and tumor-level modules. In total, 17 core CDEs (10 patient level and 7 tumor level) as well as 14 supplemental CDEs (7 patient level and 7 tumor level) were defined and described. These CDEs are now made publicly available for dissemination and adoption. CDEs provide a framework for discussion in the neuro-oncology community that will facilitate data-sharing for collaborative research projects and aid in developing a common language for comparative and pooled analyses. The meningioma-specific CDEs presented here are intended to be dynamic parameters that evolve with time and The Consortium welcomes international feedback for further refinement and implementation of these CDEs.

Sections du résumé

BACKGROUND
With increasing molecular analyses of meningiomas, there is a need to harmonize language used to capture clinical data across centers to ensure that molecular alterations are appropriately linked to clinical variables of interest. Here the International Consortium on Meningiomas presents a set of core and supplemental meningioma-specific common data elements (CDEs) to facilitate comparative and pooled analyses.
METHODS
The generation of CDEs followed the 4-phase process similar to other National Institute of Neurological Disorders and Stroke (NINDS) CDE projects: discovery, internal validation, external validation, and distribution.
RESULTS
The CDEs were organized into patient- and tumor-level modules. In total, 17 core CDEs (10 patient level and 7 tumor level) as well as 14 supplemental CDEs (7 patient level and 7 tumor level) were defined and described. These CDEs are now made publicly available for dissemination and adoption.
CONCLUSIONS
CDEs provide a framework for discussion in the neuro-oncology community that will facilitate data-sharing for collaborative research projects and aid in developing a common language for comparative and pooled analyses. The meningioma-specific CDEs presented here are intended to be dynamic parameters that evolve with time and The Consortium welcomes international feedback for further refinement and implementation of these CDEs.

Identifiants

pubmed: 34791428
pii: 6430437
doi: 10.1093/neuonc/noab259
pmc: PMC9071284
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

683-693

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Radiat Oncol. 2014 Jan 27;9:38
pubmed: 24467972
Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
J Neurooncol. 2019 Jan;141(1):103-109
pubmed: 30392090
Neuro Oncol. 2017 Sep 01;19(9):1263-1270
pubmed: 28371851
Cancers (Basel). 2019 Oct 24;11(11):
pubmed: 31652973
J Natl Cancer Inst. 2015 Dec 13;108(5):
pubmed: 26668184
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Neurooncol. 2006 Mar;77(1):73-7
pubmed: 16292489
Neurosurg Focus. 2008;24(5):E7
pubmed: 18447746
Childs Nerv Syst. 1995 Nov;11(11):661-3
pubmed: 8608584
Oper Neurosurg (Hagerstown). 2018 Mar 1;14(3):215-223
pubmed: 28541487
J Neurooncol. 2019 Oct;145(1):125-134
pubmed: 31493161
Int J Mol Sci. 2021 Jan 12;22(2):
pubmed: 33445724
BMJ Case Rep. 2015 Dec 20;2015:
pubmed: 26688430
Sci Rep. 2020 Jul 8;10(1):11220
pubmed: 32641701
Pract Radiat Oncol. 2018 May - Jun;8(3):145-152
pubmed: 29545124
Neuro Oncol. 2019 Feb 19;21(3):392-403
pubmed: 30099534
Neurosurgery. 1995 Mar;36(3):599-604; discussion 604-5
pubmed: 7753363
Neuro Oncol. 2017 Nov 29;19(12):1588-1598
pubmed: 28531331
Future Oncol. 2016 May;12(10):1261-74
pubmed: 27096309
J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39
pubmed: 13406590
Neuro Oncol. 2017 Jul 1;19(7):897-907
pubmed: 28039363
PLoS One. 2013 Dec 27;8(12):e83261
pubmed: 24386167
Neuro Oncol. 2017 Apr 1;19(4):535-545
pubmed: 28170043
Zentralbl Neurochir. 2005 Feb;66(1):17-23
pubmed: 15744624
J Neurosurg. 2013 Aug;119(2):475-81
pubmed: 23394332
J Neurooncol. 2000 Jul;48(3):233-41
pubmed: 11100821
J Neurooncol. 2010 Jul;98(3):367-72
pubmed: 20012910
Clin Cancer Res. 2017 Jun 15;23(12):e54-e61
pubmed: 28620005
Cancer Med. 2019 Oct;8(14):6458-6467
pubmed: 31475482
Acta Neurochir (Wien). 2019 Dec;161(12):2553-2561
pubmed: 31637512
Neuro Oncol. 2014 Jun;16(6):829-40
pubmed: 24500419
Radiographics. 2017 Nov-Dec;37(7):2164-2180
pubmed: 29028423
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i32-i43
pubmed: 30649488
Am J Surg Pathol. 2013 Dec;37(12):1797-814
pubmed: 24061524
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i18-i31
pubmed: 30649489
Clin Trials. 2016 Dec;13(6):671-676
pubmed: 27311638
J Neurosurg. 2011 Dec;115(6):1072-7
pubmed: 21780859
J Neurosurg. 2010 Nov;113(5):1026-7; discussion 1027-8
pubmed: 20380534
J Clin Oncol. 2017 Jul 20;35(21):2378-2385
pubmed: 28640700
J Neurosurg. 2002 Nov;97(5):1078-82
pubmed: 12450029
J Neurosurg. 2018 May;128(5):1403-1409
pubmed: 28731398
Crit Rev Oncol Hematol. 2008 Aug;67(2):153-71
pubmed: 18342535
Spine (Phila Pa 1976). 2015 Aug 1;40(15):E886-9
pubmed: 25996535
Arch Phys Med Rehabil. 2010 Nov;91(11):1661-6
pubmed: 21044709
Oncol Lett. 2016 Jun;11(6):3655-3659
pubmed: 27284369
Handb Clin Neurol. 2020;169:121-129
pubmed: 32553283
Neurochirurgie. 2016 Jun;62(3):128-35
pubmed: 27234913
J Neurosurg. 2015 Jan;122(1):4-23
pubmed: 25343186
J Neurosurg. 2004 Aug;101(2):210-8
pubmed: 15309910
J Neurosurg. 2003 Nov;99(5):848-53
pubmed: 14609164
Acta Neurochir (Wien). 2014 Feb;156(2):383-8
pubmed: 24193889
Science. 2013 Mar 1;339(6123):1077-80
pubmed: 23348505
Chin Clin Oncol. 2017 Jul;6(Suppl 1):S2
pubmed: 28595423
Am J Public Health. 2000 Nov;90(11):1714-9
pubmed: 11076237
Sci Rep. 2016 Oct 20;6:35743
pubmed: 27760993
Nat Commun. 2017 Feb 14;8:14433
pubmed: 28195122
Neurooncol Adv. 2020 Oct 16;2(1):vdaa129
pubmed: 33305267
J Neurooncol. 2019 May;143(1):137-144
pubmed: 30868355
Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):790-799
pubmed: 31786276
Br J Cancer. 2008 Jul 8;99(1):182-4
pubmed: 18577989
Nat Genet. 2013 Mar;45(3):285-9
pubmed: 23334667
World Neurosurg. 2015 Oct;84(4):1014-9
pubmed: 26038336
Brain Pathol. 2014 Mar;24(2):184-9
pubmed: 24261697
Acta Neurochir (Wien). 2019 Feb;161(2):333-341
pubmed: 30675656
Nat Commun. 2017 Aug 4;8(1):186
pubmed: 28775249
Curr Opin Oncol. 2020 Nov;32(6):613-622
pubmed: 32890025
J Neurosurg. 1983 Jan;58(1):51-6
pubmed: 6847909
J Family Med Prim Care. 2020 Mar 26;9(3):1296-1301
pubmed: 32509607
Acta Neurochir (Wien). 2018 Aug;160(8):1521-1529
pubmed: 28326464
J Neurosurg. 2012 Jul;117(1):118-9; discussion 119-20
pubmed: 22559849
J Neurooncol. 2018 Sep;139(3):749-755
pubmed: 29948766
World Neurosurg. 2018 Mar;111:e856-e862
pubmed: 29325959
World Neurosurg. 2017 Jan;97:635-644.e8
pubmed: 27713063
J Neurosurg. 2018 May 4;130(3):876-883
pubmed: 29726777
Methods Inf Med. 2006;45(6):594-601
pubmed: 17149500
J Korean Neurosurg Soc. 2017 Nov;60(6):661-666
pubmed: 29142625
Neuro Oncol. 2019 Jul 11;21(7):901-910
pubmed: 31158293
Clin Trials. 2012 Jun;9(3):322-9
pubmed: 22371630
Neurosurgery. 1991 Mar;28(3):482
pubmed: 2011241
J Neurooncol. 1996 Sep;29(3):269-72
pubmed: 8858533
Neurosurg Focus. 2018 Apr;44(4):E4
pubmed: 29606048
J Neurooncol. 2019 Dec;145(3):449-459
pubmed: 31729637
Neuro Oncol. 2019 Jan 14;21(Suppl 1):i4-i17
pubmed: 30649490
Handb Clin Neurol. 2013;111:333-40
pubmed: 23622184
Handb Clin Neurol. 2020;169:273-284
pubmed: 32553295
Curr Opin Oncol. 2012 Nov;24(6):666-71
pubmed: 22759739
Neurosurgery. 1999 Jun;44(6):1194-9; discussion 1199-200
pubmed: 10371618
Epilepsia. 2011 Jun;52(6):1186-91
pubmed: 21426327
J Neurosurg. 2017 Apr;126(4):1201-1211
pubmed: 27257838
Cancer. 2018 Jan 1;124(1):161-166
pubmed: 28902404
J Neurooncol. 2019 Nov;145(2):277-286
pubmed: 31578671
Lancet Oncol. 2017 May;18(5):682-694
pubmed: 28314689
World Neurosurg. 2020 Jun;138:e361-e369
pubmed: 32142947
Neurosurg Rev. 2021 Apr;44(2):1061-1069
pubmed: 32248508
Surg Neurol Int. 2013 May 28;4:71
pubmed: 23776757
Neurochirurgie. 2017 Sep;63(4):273-281
pubmed: 28882609
World Neurosurg. 2019 Feb;122:e1536-e1541
pubmed: 30471445
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100
pubmed: 31675094
Chin Clin Oncol. 2017 Jul;6(Suppl 1):S4
pubmed: 28758408
Neuroradiol J. 2018 Feb;31(1):18-26
pubmed: 29206077
Acta Neurochir (Wien). 2018 Sep;160(9):1813-1822
pubmed: 29961125
J Neurosurg. 2020 Oct 23;:1-9
pubmed: 33096534
J Neurooncol. 2010 Sep;99(3):307-14
pubmed: 20821343
Neurol Med Chir (Tokyo). 2017 Oct 15;57(10):521-533
pubmed: 28819091
J Neurosurg. 2015 Jul;123(1):23-30
pubmed: 25859807
Cancer Epidemiol. 2019 Oct;62:101562
pubmed: 31325769
Acta Neurochir (Wien). 2001;143(6):547-53
pubmed: 11534671
Neuro Oncol. 2012 May;14(5):658-66
pubmed: 22406926
Eur Geriatr Med. 2018;9(1):95-101
pubmed: 29430269
Oncotarget. 2018 Feb 15;9(22):16087-16098
pubmed: 29662628
Neuro Oncol. 2014 May;16(5):735-47
pubmed: 24536048
NPJ Digit Med. 2020 Jan 30;3:12
pubmed: 32025573
J Neurosurg. 1984 Jan;60(1):52-60
pubmed: 6689728
Radiat Oncol. 2019 Sep 2;14(1):160
pubmed: 31477146
Acta Neurochir (Wien). 2017 Mar;159(3):435-445
pubmed: 28101641
J Neurooncol. 2010 Sep;99(3):341-7
pubmed: 20714782
Arch Phys Med Rehabil. 2010 Nov;91(11):1641-9
pubmed: 21044707
World Neurosurg. 2018 Jan;109:e292-e297
pubmed: 28987830
Clin Neurol Neurosurg. 2016 Feb;141:117-21
pubmed: 26780494
Neuroradiol J. 2012 Sep;25(4):423-6
pubmed: 24029035
Neuro Oncol. 2015 Jan;17(1):116-21
pubmed: 25100872
J Neurosurg. 2020 Oct 9;:1-8
pubmed: 33035995
Neurosurgery. 2019 Sep 1;85(3):E461-E469
pubmed: 30566646
J Biomed Inform. 2013 Apr;46(2):259-65
pubmed: 23149159
Neuro Oncol. 2019 Jan 1;21(1):26-36
pubmed: 30137421
Stereotact Funct Neurosurg. 2004;82(4):194-5
pubmed: 15557769
Neurosurgery. 2001 Nov;49(5):1029-37; discussion 1037-8
pubmed: 11846894
J Neuropathol Exp Neurol. 2000 Jul;59(7):614-20
pubmed: 10901233
Expert Rev Neurother. 2012 Oct;12(10):1189-95; quiz 1196
pubmed: 23082735
Acta Neuropathol. 2020 Sep;140(3):409-413
pubmed: 32642869
Skull Base. 2007 May;17(3):157-71
pubmed: 17973029
World Neurosurg. 2017 Oct;106:975-977
pubmed: 28985658
Neurochirurgie. 2018 Mar;64(1):5-14
pubmed: 25249493
Case Rep Surg. 2013;2013:131962
pubmed: 24069543
Methods Inf Med. 2015;54(5):455-60
pubmed: 26394900
J Neurosurg Pediatr. 2017 Jul;20(1):42-50
pubmed: 28474981
J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387
pubmed: 32041819
J Neurooncol. 2017 Sep;134(2):407-416
pubmed: 28667597
Clin Neurol Neurosurg. 2017 Jul;158:119-125
pubmed: 28527972
Clin Cancer Res. 2020 Feb 1;26(3):552-557
pubmed: 31969329
J Neurol Surg B Skull Base. 2019 Dec;80(6):555-561
pubmed: 31750040
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Neurosurgery. 1989 Oct;25(4):541-5
pubmed: 2797392
Neurooncol Pract. 2020 Jun;7(3):320-328
pubmed: 32528713
Chin Clin Oncol. 2017 Jul;6(Suppl 1):S7
pubmed: 28758410
Expert Rev Neurother. 2018 Mar;18(3):241-249
pubmed: 29338455
J Neurosurg. 2017 Jun;126(6):1772-1778
pubmed: 27341048
Expert Rev Neurother. 2011 Oct;11(10):1425-32
pubmed: 21955199
N Engl J Med. 2015 Jun 25;372(26):2481-98
pubmed: 26061751
Handb Clin Neurol. 2020;170:167-174
pubmed: 32586488
Sci Rep. 2020 Jan 15;10(1):303
pubmed: 31941981
J Pak Med Assoc. 2018 May;68(5):819-821
pubmed: 29885194
J Neurooncol. 2017 Jul;133(3):641-651
pubmed: 28527009
Cureus. 2020 Mar 18;12(3):e7304
pubmed: 32313745
Mayo Clin Proc. 2019 Feb;94(2):254-261
pubmed: 30711123
Neuro Oncol. 2017 Oct 19;19(11):1447-1456
pubmed: 28482042
Nat Genet. 2016 Oct;48(10):1253-9
pubmed: 27548314
Cancer. 2011 Mar 15;117(6):1272-8
pubmed: 21381014
Eur J Cancer Prev. 2016 Jan;25(1):29-33
pubmed: 25642792
Surg Neurol Int. 2015 Apr 20;6:64
pubmed: 25949852
Front Oncol. 2020 Apr 15;10:503
pubmed: 32351890
JCO Clin Cancer Inform. 2020 Oct;4:993-1001
pubmed: 33136433
Neurochirurgie. 2020 Apr;66(2):73-79
pubmed: 32145249

Auteurs

Farshad Nassiri (F)

MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Justin Z Wang (JZ)

MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Karolyn Au (K)

Division of Neurosurgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

Jill Barnholtz-Sloan (J)

Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA.

Michael D Jenkinson (MD)

Department of Neurosurgery, University of Liverpool, Liverpool, UK.

Kate Drummond (K)

Department of Neurosurgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Yueren Zhou (Y)

Department of Biostatistics, Henry Ford Health System, Detroit, Michigan, USA.

James M Snyder (JM)

Department of Neurology, Henry Ford Health System, Detroit, Michigan, USA.

Priscilla Brastianos (P)

Dana Farber/Harvard Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Thomas Santarius (T)

Department of Neurosurgery, Cambridge University Hospitals, Cambridge, UK.

Suganth Suppiah (S)

MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Laila Poisson (L)

Department of Biostatistics, Henry Ford Health System, Detroit, Michigan, USA.

Francesco Gaillard (F)

Department of Radiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Mark Rosenthal (M)

Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Timothy Kaufmann (T)

Department of Radiology, The Mayo Clinic, Rochester, Minnesota, USA.

Derek S Tsang (DS)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Kenneth Aldape (K)

National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Gelareh Zadeh (G)

MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH